[Systemic treatments in older patients with cancer].

The number of older patients with cancer is increasing dramatically. Recently , new anti-tumour therapies have led to significant advances in both curative and metastatic situations, with the arrival of immunotherapies as monotherapy or in combination with chemotherapy or targeted therapies, including antibody-drug conjugates. However, these new treatments have been little evaluated in elderly cancer patients, who are rarely included in therapeutic trials and require numerous adjustments to their intensity due to the increasing underlying frailty associated with age.